About Agresera
Agresera is a company based in Vannasby (Sweden) founded in 2004 was acquired by Olink in May 2020.. Agresera offers products and services including Plant/Algal Antibodies, Secondary Antibodies, Compartment Markers, ELISA Kits, and Photosynthesis Antibodies. Agresera operates in a competitive market with competitors including Sino Biological, GenScript, Mabtech, Y-Biologics and Epitomics, among others.
- Headquarter Vannasby, Sweden
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Agrisera Ab
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Agresera
Agresera offers a comprehensive portfolio of products and services, including Plant/Algal Antibodies, Secondary Antibodies, Compartment Markers, ELISA Kits, and Photosynthesis Antibodies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Antibodies for detecting plant and algal proteins in studies.
Reagents for enhancing antibody-based assays in biology.
Markers for identifying cellular compartments in plants.
Kits for quantifying hormones and proteins in research.
Antibodies targeting photosynthesis components like PSI and PSII.
Funding Insights of Agresera
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $1.8M
-
First Round
First Round
(01 May 2016)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2018 | Amount | Grant - Agresera | Valuation |
investors |
|
| May, 2016 | Amount | Grant - Agresera | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Agresera
Agresera has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Olink, European Union and EIC Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
Provider of products and services for human protein biomarker research and development
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Agresera
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Agresera
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Agresera Comparisons
Competitors of Agresera
Agresera operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sino Biological, GenScript, Mabtech, Y-Biologics and Epitomics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Reagents and kits are provided for clinical research applications.
|
|
| domain | founded_year | HQ Location |
Reagents and instruments are provided for life sciences research.
|
|
| domain | founded_year | HQ Location |
Antibodies and immunoassay kits are developed for research applications.
|
|
| domain | founded_year | HQ Location |
Developer of antibodies for the treatment of multiple diseases
|
|
| domain | founded_year | HQ Location |
Monoclonal antibody technology and products are developed by Epitomics.
|
|
| domain | founded_year | HQ Location |
Technology for antibody-drug conjugation is provided by AbTis.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Agresera
When was Agresera founded?
Agresera was founded in 2004 and raised its 1st funding round 12 years after it was founded.
Where is Agresera located?
Agresera is headquartered in Vannasby, Sweden. It is registered at Vannasby, Vasterbotten, Sweden.
What does Agresera do?
Agresera was established in 2004 in Vannasby, Sweden, within the biotechnology sector focused on research tools. Primary and secondary antibodies for plant, human, and animal applications are provided, alongside bacterial and fungal antibodies. Rapid western blotting kits and detection reagents are also offered to support laboratory operations in these fields.
Who are the top competitors of Agresera?
Agresera's top competitors include Sino Biological, GenScript and Y-Biologics.
What products or services does Agresera offer?
Agresera offers Plant/Algal Antibodies, Secondary Antibodies, Compartment Markers, ELISA Kits, and Photosynthesis Antibodies.
Who are Agresera's investors?
Agresera has 3 investors. Key investors include Olink, European Union, and EIC Fund.